Immediate Impact
46 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
2024 Standout
Works of Annick S. Devos being referenced
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Annick S. Devos | 122 | 67 | 57 | 130 | 68 | 11 | 337 | |
| Sven Gutsche | 50 | 42 | 41 | 47 | 41 | 9 | 378 | |
| Maria Teresa Farrés | 214 | 62 | 52 | 57 | 33 | 17 | 377 | |
| Dominic A. Hovsepian | 45 | 23 | 18 | 117 | 113 | 11 | 404 | |
| C. Gustafson | 37 | 52 | 75 | 37 | 81 | 12 | 380 | |
| Sumit Kumar | 67 | 78 | 28 | 48 | 47 | 11 | 303 | |
| Luis A. Guerra | 56 | 170 | 39 | 144 | 36 | 15 | 357 | |
| Thomas P. Ball | 147 | 216 | 36 | 26 | 33 | 20 | 356 | |
| Toshihiko Terao | 40 | 28 | 26 | 142 | 23 | 12 | 391 | |
| Mario F. Rubin | 135 | 48 | 47 | 100 | 11 | 14 | 364 | |
| Ólafur Thorarensen | 51 | 38 | 3 | 100 | 85 | 9 | 320 |
All Works
Loading papers...